Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Yeast and fungal beta-glucan

Yeast Beta-(1,3/1,6)-D-Glucan · also known as Yeast glucan, Fungal polysaccharide, Beta-1,3/1,6-D-glucan

Yeast beta-glucan is recognized by the Dectin-1 receptor, which then activates macrophages and neutrophils. After oral intake, the evidence for signal activation and trained immunity in humans rests only on small studies of transcriptional markers, and it still needs confirming.

Typical dose: 100–500 mg/day (high-purity, yeast-derived branched beta-1,3/1,6 glucan)
Absorption and forms: Intact polysaccharide should not be assumed to pass directly into the blood after oral intake. Animal studies suggest some particles may be sampled by intestinal M cells and delivered to lymphoid tissue. This transport route depends on the formulation and particle size, and not all polysaccharides follow the same route.

Clinical uses and human evidence

Colds: prevention and duration

BeneficialGrade B · Moderate evidence
Studies (2)
  1. Zhong 2021 · Eur J Nutr · Meta-analysis — Effects of yeast β-glucans for the prevention and treatment of upper respiratory tract infection in healthy subjects: a systematic review and meta-analysis
  2. Habibullah 2026 · iScience · RCT · n=198 — Low-dose of yeast beta-glucan on respiratory symptoms and psychological well-being in moderately stressed adults

Anxiety and stress

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Habibullah 2026 · iScience · RCT · n=198 — Low-dose of yeast beta-glucan on respiratory symptoms and psychological well-being in moderately stressed adults

Low mood

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Habibullah 2026 · iScience · RCT · n=198 — Low-dose of yeast beta-glucan on respiratory symptoms and psychological well-being in moderately stressed adults

Mechanisms of action

Pattern recognition receptor (PRR) immune surveillance and trained immunity

★★★★☆Mechanism evidence: grade BPrimary target

Recognition of yeast beta-glucan by Dectin-1 is its core mechanism. Activation of the Syk-CARD9 pathway and trained immunity after oral intake in humans remain to be verified. A small placebo-controlled trial in 19 people measured changes in only some related transcripts.

References (2)
  1. McFarlin et al. 2025 · Small randomized placebo-controlled trial: in 19 people taking oral yeast beta-glucan, some transcripts related to Dectin-1 and trained immunity changed
  2. 2014 · Human randomized pilot study: no clear enhancement of leukocyte bactericidal function was observed

Colonic short-chain fatty acid (SCFA/butyrate) fermentation substrate and receptor activation

★★☆☆☆Mechanism evidence: grade C

In mouse experiments, some yeast polysaccharides can change the gut microbiota and fecal short-chain fatty acids, and results vary by formulation. An exploratory human trial did not observe significant changes in fecal short-chain fatty acids, so yeast beta-glucan should not be regarded as a reliable source of short-chain fatty acids.

References (2)
  1. 2020 · Mouse study: a complex yeast-derived polysaccharide altered gut microbiota and fecal short-chain fatty acids
  2. Cronin et al. 2024 · Exploratory human trial: yeast beta-1,3/1,6-glucan did not significantly change fecal short-chain fatty acids

Safety and drug interactions

Use with caution in people taking immunosuppressants after organ transplant. During flares of acute severe autoimmune disease, follow a doctor’s advice.

Immune stimulation

Activates innate immune cells. Each of these stimulates immune responses. They may counteract immunosuppressant drugs, and caution is also needed during active autoimmune disease.

Open in the interactive app ›